Navigation Links
MU researchers go nano, natural and green
Date:10/31/2007

ature for assistance. They found that by submersing gold salts in water and then adding soybeans, gold nanoparticles were generated. The water pulls a phytochemical(s) out of the soybean that is effective in reducing the gold to nanoparticles. A second phytochemical(s) from the soybean, also pulled out by the water, then interacts with the nanoparticles to stabilize them and keep them from fusing with the particles nearby. This process creates nanoparticles that are uniform in size in a 100 percent green process.

This fits with what we need to do for the future, said Kannon, assistant professor of radiology. We are solving a pollution problem at the very beginning stages of a developing technology. We dont anticipate any waste or byproducts from this new process that would not be biodegradable. Every one of these compounds involved in the process already exists in nature.

The new discovery has created a very large positive response in the scientific community. Researchers from as far away as Germany have been commenting on the discoverys importance and the impact it will have in the future.

Soy is grown worldwide and Dr. Kattis Nobel Prize winning discovery will ensure that gold nanoparticles-based Nanomedicine products would be made available even to the less developed regions of the world, said B. R. Barwale, 1998 winner of the world food prize and founder of Maharashtra Hybrid Seeds Company in India.

Dr. Kattis discovery sets up the beginning of a new knowledge frontier that interfaces plant science, chemistry and nanotechnology, said Herbert W. Roesky, a professor and world renowned chemist from the University of Goettingen in Germany.

Katti, Kannan, Henry White, MU professor of physics, and Kavita Katti, a senior research chemist, have filed a patent for the new process and developed a new company, Greennano Company, which focuses on development, commercialization and world wide supply of green nanoparticles for med
'/>"/>

Contact: Christian Basi
BasiC@missouri.edu
573-882-4430
University of Missouri-Columbia
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Researchers find how protein allows insects to detect and respond to pheromones
3. Researchers Uncover Key Step In Manufacture of Memory Protein
4. NYU researchers simulate molecular biological clock
5. Researchers reveal the infectious impact of salmon farms on wild salmon
6. Researchers identify target for cancer drugs
7. Vital step in cellular migration described by UCSD medical researchers
8. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
9. UCSD researchers maintain stem cells without contaminated animal feeder layers
10. Researchers discover molecule that causes secondary stroke
11. Researchers find missing genes of ancient organism
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:EUCODIS Bioscience Appoints Thomas Fischer as New CEO 2Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 2Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2